BioXcel Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2018 to Q4 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
BioXcel Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2018 to Q4 2024.
  • BioXcel Therapeutics, Inc. Current Ratio for the quarter ending December 31, 2024 was 216 %, a 42.2% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 216 -158 -42.2% Dec 31, 2024
Q3 2024 238 -217 -47.7% Sep 30, 2024
Q2 2024 252 -383 -60.3% Jun 30, 2024
Q1 2024 293 -532 -64.4% Mar 31, 2024
Q4 2023 374 -599 -61.6% Dec 31, 2023
Q3 2023 454 -770 -62.9% Sep 30, 2023
Q2 2023 635 -772 -54.9% Jun 30, 2023
Q1 2023 825 -813 -49.6% Mar 31, 2023
Q4 2022 972 -754 -43.7% Dec 31, 2022
Q3 2022 1.22K -626 -33.8% Sep 30, 2022
Q2 2022 1.41K -343 -19.6% Jun 30, 2022
Q1 2022 1.64K +371 +29.2% Mar 31, 2022
Q4 2021 1.73K +657 +61.5% Dec 31, 2021
Q3 2021 1.85K +1.06K +133% Sep 30, 2021
Q2 2021 1.75K +1.25K +247% Jun 30, 2021
Q1 2021 1.27K +752 +146% Mar 31, 2021
Q4 2020 1.07K +608 +132% Dec 31, 2020
Q3 2020 793 +236 +42.4% Sep 30, 2020
Q2 2020 504 -241 -32.4% Jun 30, 2020
Q1 2020 516 -692 -57.3% Mar 31, 2020
Q4 2019 461 -1.15K -71.4% Dec 31, 2019
Q3 2019 557 -1.01K -64.4% Sep 30, 2019
Q2 2019 745 Jun 30, 2019
Q1 2019 1.21K Mar 31, 2019
Q4 2018 1.61K Dec 31, 2018
Q3 2018 1.56K Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.